Agoracom Blog Home

Posts Tagged ‘CSE’

My Search for the Healthiest Baby Formula – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:12 PM on Thursday, May 7th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

My Search for the Healthiest Baby Formula

by Robin Barrie Kaiden, MS, RD, CDN

Robin Barrie Kaiden, MS, RD, CDN is renowned for helping people of all ages embrace a healthier lifestyle through nutrition and fitness counseling.  As a Licensed Registered Dietitian and Personal Trainer, her smart and sensible approach to pediatrics, weight loss, sports nutrition, allergies, cardiovascular health, pre/post natal, and other areas of clinical and lifestyle nutrition has resonated with hundreds of people across the United States. Robin received her B.S. and M.S. degrees in Nutrition and Exercise Science from Cornell and Columbia Universities.

A Personal Note from this Pediatric Registered Dietitian and Mom

When I began working as a Registered Dietitian in Pediatric Nutrition over 15 years ago, we, of course, were taught, and shared with patients, that breast milk was the best, healthiest option for feeding babies.  When that wasn’t possible, sufficient, or babies were being weaned, I knew that there were a variety of infant and toddler formulas available. We could recommend:

  1. Pre-term infant formula:  higher calories and minerals for infants born early
  2. Standard term infant formula:  intact milk protein
  3. Gentle/sensitive formulas: whey protein in milk partially broken down
  4. Soy-based formulas:  for those with milk intolerance, noting that over 50% of infants who don’t tolerate dairy, also do not tolerate soy protein
  5. Hydrolyzed formulas:  proteins are mostly, but not completely broken down
  6. Elemental formulas:  proteins completely broken down for severe milk allergies

At this point in my career, I did not study the ingredients of each, but rather selected the best option available to best aid in tolerance, intake and growth for the child.  There always seemed to be one that worked well…..at least well enough. The biggest problem with the hydrolyzed and elemental formulas was that they smelled and tasted terrible, and babies often refused to drink them.

Over 8 years ago, when I was pregnant with my first baby, I began to examine the healthiest baby formula options more in depth.   I discovered that not much had changed in this industry, except that there were a couple of organic options. After discussing with a colleague, I decided on a formula.  When my son was less than a week old, this product was recalled due to high arsenic levels. Plus, it seemed to upset his stomach. When my baby nurse suggested a non-organic, but “gentle” formula, I (reluctantly) agreed.  I disliked that it had corn syrup (processed inflammatory sugar) as one of the main ingredients, but I was a new mom, overwhelmed, and figured she had so much experience and knew what she was talking about. Plus, my pediatrician agreed as well.  A few weeks later, I just went back to the only other organic option on the market, and my son seemed to tolerate it well enough. It was the best I could find at that time. 

When it came time to find the healthiest baby formula for my second child, almost 2.5 years later, I become aware that there were some European products that had better ingredients.  However, it was pretty difficult and expensive to get these in the U.S. back then. I took comfort in the fact that my baby would be able to get great nutrition in the form of real food within about 4-5 months, and wean off formula totally at 1 year.  But all I could think was that I would love to create a new healthy baby formula myself. Why hadn’t someone come up with a better alternative yet? Aren’t the infant and toddler stages the most important as they are developing and growing so rapidly? Why wouldn’t everyone want offer the best possible nutrients to this group, if/when/after breast milk was not an option.

My children are now in elementary school and the infant/toddler formula industry is still, in my opinion extremely limited.  I was thrilled to hear about Else Nutrition, and flattered to consult on their timely products. Formulation of plant-based products is way overdue.   In the wake of a huge movement towards plant-based and plant-forward diets, due to increased research and interest, Else is a wonderful product to support infant and toddler Nutrition.  Read on to learn about all of its positive attributes.

Benefits of Else Plant-Based Formula Alternative

Choose Else Nutrition because it is:

  1. Organic:  This means that the USDA (United States Department of Agriculture) has determined that the ingredients in this healthy baby formula are free of genetically modified organisms (GMOs), fungicides, herbicides, and pesticides.   Organic practices result in enhanced soil and water quality and, in general, more overall sustainable farming (1).  Translation:  Organic foods are beneficial for our environment.  Research has shown that organic produce is more nutritious:  It has higher levels of antioxidants and lower levels of toxic metals (such as Cadmium).   Increased exposure to pesticides has been shown to increase risk for ADHD, Parkinson’s disease, diabetes, and some cancers (2).  The effects of chemicals used in conventional farming may be more detrimental to the small developing brains and bodies of babies/children than to those of adults. 
  2.  Glyphosate-free:  Yes, the USDA Organic Label is important, however, it may not be enough today.  It ensures that crops are GMO-free, but this doesn’t mean a product is 100% free of pesticides.   Glyphosate is an herbicide (pesticide) that is carcinogenic (can cause cancer). Final organic food products are often NOT tested.  The USDA does not check for glyphosate residue. The buckwheat and almond sources in Else formulas are glyphosate-free.
  3. Made from clean ingredients:  Else formulas are simple and pure.  Almonds, buckwheat, and tapioca make up about 92% of the product.  The ingredient list is short and easy to understand. There are no added unhealthy oils, inflammatory sugar/corn syrups, artificial sweeteners, or gums/stabilizers/fillers than can upset small bellies.   For moms looking to supplement breast milk or wean their children after 1 year of age, it may seem that there are many dairy-free milk substitutes and products on the market today; however, none are quite right for little developing brains and bodies.  They are not nearly as nutritionally dense as breast milk (or full-fat dairy milk). They may be low-fat, low in protein, and other nutrients, and often contain added sugars and fillers as mentioned above. They are simply NOT appropriate, and in fact, unhealthy as a foundation for a toddler’s diet.  This is especially true for vegans and/or those who truly cannot tolerate dairy protein.
  4. Pleasantly mild in flavor:  When babies are weaned off breast milk and/or need a supplement or substitute for human or cow’s milk, they are more likely to accept a drink/formula that tastes great (they are indeed little humans).  Other formulas may not be as mild.  In fact, the hydrolyzed/elemental formulas have a reputation of smelling bad and tasting worse.  Such formulas may be indicated for little ones with dairy allergies and intolerances, and digested well; however, if the child will not drink due to the smell/taste, this can be an issue.  
  5. Vegan/Plant-based:  In case you haven’t noticed, there has been a huge buzz surrounding “plant-based” and “plant-forward” nutrition.  This is not new news to us health professionals. We have always known that a variety of fruits, vegetables, whole grains, legumes, fiber, and healthy fats were integral for good health.  The research is finally catching up. We now know that our microbiome (the collection of microorganisms-bacteria, fungi, viruses-that live in/on the human body) can benefit our health, especially immunity, aging, digestion, metabolism, mood and mental health.   We can best benefit our microbiome by consuming a diet rich in a variety of plant-based foods. Why not start our little ones on such a diet with a plant-based formula?! Research shows that children on a predominantly plant-based diet have increased microbial biodiversity and richness (3).  
  6. Dairy-Free and Soy-free:  Infants and toddlers with food allergies, intolerances, and/or sensitivities simply cannot tolerate many formulas on the market today.  The incidence of food allergies is on the rise in children and adults. According to the Mayo Clinic: “Food allergy is an immune system reaction that occurs soon after eating a certain food. Even a tiny amount of the allergy-causing food can trigger signs and symptoms such as digestive problems, hives or swollen airways. In some people, a food allergy can cause severe symptoms or even a life-threatening reaction known as anaphylaxis.”(4)  Cow’s milk is the most allergenic food for in children in the U.S. (followed by peanuts, eggs and soy).  Most of the formulas on the market are based on cow’s milk.  

Else’s products can be tolerated by children with dairy and soy allergies and sensitivities.  Anaphylaxis due to almond or buckwheat allergy is very rare (<1% and 1% of anaphylaxis cases in children respectively) with numbers well below egg, wheat, fish, goat/sheep’s milk, lentils, cashew, and peanut.

Also, just as an update and reminder about almonds:  recent research demonstrates that delaying introduction of potential allergenic foods (wheat, dairy, eggs, fish and nuts) may actually increase the risk of food allergies and/ or eczema.  The American Academy of Asthma, Allergy and Immunology (AAAAI) now recommends they be introduced without delay, and not wait up to 1-3 years of age, as advised in the past (5).

  1. Nutrient composition matches breast milk:  We all know that breast milk is the gold standard for feeding infants.  However, if and when it is not possible, and/or a child requires supplementation or is being weaned, Else Nutrition provides a formula with nutrients that match that of breast milk.  The macronutrients (carbohydrates, fat, and protein) and micronutrients (vitamins and minerals) are the same in Else formula-even though Else is a vegan product. Moms and caregivers can be confident that their babies are being nourished while they slowly learn how to eat solids.   
  2. Created and supported by the best team:  These formulas were created by leaders in the infant and toddler nutrition industry.   Their formulation and ingredients have been tested, approved, and supported by pediatricians, gastroenterologists, registered dietitians, and MOMS and DADS!  

References:

  1. https://www.ams.usda.gov/sites/default/files/media/Organic%20Practices%20Factsheet.pdf
  2. https://www.ncbi.nlm.nih.gov/pubmed/29073935
  3. https://www.ncbi.nlm.nih.gov/pubmed/20679230
  4. https://www.mayoclinic.org/diseases-conditions/food-allergy/symptoms-causes/syc-20355095
  5. https://www.jaci-inpractice.org/article/S2213-2198(12)00014-1/fulltext

Source: https://elsenutrition.com/blogs/news/my-search-for-the-healthiest-baby-formula

Online education now a new normal for govt, #Edtech platforms – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 10:39 AM on Thursday, May 7th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

Online education now a new normal for govt, edtech platforms

  • As millions of kids take online school classes from home globally including in India, government along with private education sector have a great responsibility to offer online e-Learning to more than 60 million college students and 1.5 billion school students worldwide, experts said on Thursday

Private colleges in India which were already offering online education for last two decades now have a massive surge in e-Learning demand to meet.

“e-Learning or online education is the new normal. In future, we will see the proliferation of information technology tools and gadgets, post-COVID-19. But internet and broadband will remain an issue,” said Professor NK Goyal, Vice Chairman, ITU APT India and former adviser of Gujarat Technological University.

If e-Learning apps like BYJU’s and Khan academy are targeting schools, others like Adda24x7 are offering specialised coaching for entrance exams like IIT and JEE.

Robust connectivity is undoubtedly critical for the success of e-Learning.

According to Rajan S Mathews, DG, the Cellular Operators Association of India (COAI), post COVID-19, there will be a surge in online education by schools and colleges in the country.

“The telecom industry is fully prepared with 99.9 per cent network capacity. The telecom companies have taken appropriate measures to meet the surge in traffic due to online education and other online activities using telecom infrastructure,” said Mathews.

Union Human Resources and Development (HRD) Minister Ramesh Pokhriyal Nishank recently said that the government is offering a slew of educational applications and platforms for both school and higher education institutes.

In addition to teachers, Nishank urged parents and students to make maximum use of online education to ensure their academic continuity is maintained.

The World University of Design (WUD) claims that it has collected materials for online learning across its courses during the last one year.

“WUD is using technology-enabled AI, supervision technologies and video conferencing and other tools to enable virtual learning. This includes a mix of online platforms for sharing files, conducting meetings and lectures in association with online services iamp; resource providers like Coursera, Bloomsbury, EBSCO etc. as partners in its strategy,” said Dr Sanjay Gupta, Vice Chancellor, World University of Design (WUD).

Source: https://www.newkerala.com/news/2020/80541.htm

#AI can distinguish between bots and humans based on #Twitter activity – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 10:08 AM on Thursday, May 7th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI can distinguish between bots and humans based on Twitter activity

  • Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter
  • Researchers found that human users replied between four and five times more often to other tweets than bots did
  • Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use

By Donna Lu

Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter.

Emilio Ferrara at the University of Southern California and his colleagues have trained an AI to detect bots on Twitter based on differences in patterns of activity between real and fake accounts.

The team analysed two separate data sets of Twitter users, which had been classified either manually or by a pre-existing algorithm as either bot or human.

The manually verified data set consisted of 8.4 million tweets from 3500 human accounts, and 3.4 million tweets from 5000 bots.

The researchers found that human users replied between four and five times more often to other tweets than bots did. Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use.

The length of tweets by human users also decreased as sessions progressed. “The amount of information that is exchanged diminishes,” says Ferrara. He believes that the change may result from a cognitive depletion over time, in which people become less likely to expend mental effort composing original content.

Bots, on the other hand, show no changes in their interactivity or the length of information they tweet over time.

Read more: https://www.newscientist.com/article/2241327-ai-can-distinguish-between-bots-and-humans-based-on-twitter-activity/#ixzz6LlMIFlYe

North Bud Farms $NBUD.ca Provides Update on U.S. and Quebec Subsidiaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:16 AM on Wednesday, May 6th, 2020
  • Quebec government recently announced that, effective May 11, 2020, it will begin easing its Covid-19 related restrictions on business operations in the province
  • Subject to the implementation of said easing measures, NORTHBUD intends to commence scaling its Quebec production accordingly

TORONTO, May 06, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to provide shareholders with the following corporate update:

Quebec Cultivation Facility

Easing of Covid-19 Restrictions

The Quebec government recently announced that, effective May 11, 2020, it will begin easing its Covid-19 related restrictions on business operations in the province. Subject to the implementation of said easing measures, NORTHBUD intends to commence scaling its Quebec production accordingly, and has advised its suppliers that it will be ready to receive starting materials quickly upon implementation of the easing measures.

Outdoor Cultivation Licence Application Status

With respect to the Company’s previously disclosed intention to apply for an amendment to its existing cultivation licence at its Quebec facility to allow for outdoor cultivation, the Company is pleased to announce that it has submitted to Health Canada all required materials and documentation for the aforementioned licence amendment, and it now awaits the issuance of a licence to allow for a proposed 1 million square feet of outdoor production.  “With the underlying fundamentals and low-cost capacity of our Quebec facility, especially with the expected addition of outdoor capacity, we believe this facility has the potential to add value and we continue to explore collaborations with companies who have established distribution channels and who are relying on the volatile wholesale market to fulfill their cultivation needs,” said Ryan Brown, the Company’s Executive Chairman and Interim CEO.  â€œManagement is encouraged by the amount of interest being shown for potential collaborations and will update shareholders when there are any material developments on this front.”

To date the Company has signed a letter of intent to supply product to a licensed distributor, and is actively negotiating additional supply contracts with other parties.  Securing these supply agreements is expected to provide the Company with further insight into revenue potential and operating capital required for its Quebec facility.  While the Company has initiated operations at its Quebec facility, currently the Company does not have sufficient working capital and financial resources to commercialize the full capacity of its Quebec facility.

Furthermore, in light of current market conditions, the Company is exploring options to extend its cash runway to further operations, including with respect to staffing decisions.

U.S. Operations

The Company also announces that it has signed a non-binding letter of intent to sell all the shares of its U.S. subsidiary, Bonfire Brands USA, Inc. (“BBUSA”), to an entity controlled by Mr. Justin Braune, the President of BBUSA.  The proposed transaction is expected to close on or before May 15, 2020, and would constitute a related-party transaction as defined in Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The proposed transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the shares of BBUSA proposed to be sold to the acquiror does not exceed 25% of the Company’s market capitalization.  This determination is based upon the fact that the value of the net assets of BBUSA is negligible as the assets acquired were, and continue to be, highly leveraged.  In light of the current market conditions, it is no longer economically viable for the Company to continue to try to sustain and develop these assets.

Under the terms of the proposed transaction, which remain subject to the negotiation of a definitive share purchase agreement and customary closing conditions and approvals, the acquiring party will become responsible for and guarantee all of BBUSA’s past and future liabilities and capital requirements, including all of the outstanding intercompany debts owed to NORTHBUD.  The acquiror will also retain rights to the name “Bonfire Brands” and the Company will no longer proceed with the change of name and symbol that was approved at the last shareholder meeting.  Final terms of the proposed transaction will be announced upon the signing of the definitive agreement.  

“The structure of this proposed transaction represents the furtherance of the Company’s previously-announced plan to remove its direct exposure to the U.S. cannabis sector in order to eliminate the increasing administrative and capital costs associated with such holdings.  Subject to the structuring of the definitive agreement, this proposed transaction would also significantly reduce dilution of shareholders of the Company by eliminating the need to issue additional shares of NORTHBUD related to the U.S. acquisitions,” said Ryan Brown, NORTHBUD’s Executive Chairman and Interim CEO.  “We look forward to the successful completion of this deal to divest our U.S. holdings, which will significantly improve the Company’s balance sheet and available cash flow, a key Company objective in light of the difficult economic climate brought on by Covid-19.”

About North Bud Farms Inc.

NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking Statements

Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, those regarding the timing of the Company’s filing of its year-end and quarterly financial statements, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to close its proposed sale of BBUSA, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Datametrex $DM.ca Obtains Rights to Sell #COVID19 Tests From Two Additional South Korean Manufacturers

Posted by AGORACOM-JC at 7:32 AM on Wednesday, May 6th, 2020
  • Secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration
  • Approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices for the United States, and CE marking certification (for European Economic Area countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit

TORONTO, May 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration (“FDA”) approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”) for the United States, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit.

According to each of the manufacturers, these test kits made are both Nucleic Acid based, which Health Canada is prioritizing the review of. Each of the manufacturers’ test kits have been submitted to Health Canada approval on a fast track basis and, until such approval is granted, these tests may not be sold or used in Canada. The Company is currently working closely with Health Canada to have the approval of the test kits fast tracked. An Interim Order Request for Health Canada has been submitted for 300,000 kits immediately and an additional 100,000 weekly thereafter.

One of the test kits, manufactured by Seasun Biomaterials (“Seasun”) Inc. of South Korea, was authorized on April 27, 2020 by the FDA in the United States for Emergency Use under the EUA by authorized laboratories and has also been approved for use in the EEA with CE marking certification. With regard to the FDA authorization: (1) this test has not been FDA cleared or approved; (2) this test has been authorized by the FDA only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and (3) this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Seasun claims that the average number of specimens that can be tested in a 12 hour period with their U-TOP COVID-19 Real-Time Detection Kit is 3,400. Seasun advises this is the equivalent of approximately 283 tests per hour, and the kit uses dual-labeled peptide nucleic acid probes to detect two distinct regions in ORF1ab and one region in N gene of the SARS-CoV-2 genome in oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, and sputum. The test runs on any authorized RT-PCR instrument and can be performed by any lab CLIA-certified to perform high-complexity tests.

Seasun is an in vitro diagnostic company that develops molecular diagnostic platforms of infection diseases, cancer as well as genetic and epigenetic disorders. Seasun develops and commercializes innovative real-time PCR-based diagnostic platforms through the development of its proprietary technologies to provide more advanced molecular diagnostic services. Seasun’s test kits will be distributed by its third party distributor, which Datametrex has agreements in place with for distribution globally. The other manufacturer that Datametrex has obtained sales rights from has requested not to be named publicly at this time.

The Company announced on April 21, 2020 the appointments of Dr. Joseph Curtis and Dr. Lisa Palleson-Stallan to the advisory board in anticipation of securing US FDA EUA approval on the test kits. Selling into the US market requires infrastructure and a qualified contact person that can assist not only in identifying opportunities to sell the test kits but also with the compliance requirements. The Company is continuing to work with Health Canada with respect to the application for approval of previously announced iONEBIO Inc. COVID-19 test kits.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA under EUA approved test kits allow us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Marshall Gunter, CEO of the Company.

The Company’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, the manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

The Company did not pay consideration to either of the manufacturers to obtain sales rights. Seasun’s application to have its test approved by Health Canada were submitted directly by Seasun, while Datametrex submitted an application for approval with respect to the other manufacturer’s tests.

About CE Marking

CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards. This makes the CE marking recognizable worldwide even to people who are not familiar with the European Economic Area (the 27 member states of the EU, the 4 members of European Free Trade Association (“EFTA”), plus Turkey and United Kingdom). CE marking also supports fair competition by holding all companies accountable to the same rules. For more information please consult the European Commission website at: CE marking.

About Food and Drug Administration EUA

On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens – Advisor
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

St-Georges Announces Permits Have Been Obtained for Iceland #Gold Projects

Posted by AGORACOM-JC at 4:35 PM on Tuesday, May 5th, 2020
  • Received permits, and thus, the green light for its 2020 seasonal work programs for the Vopnafjordur and Trollaskagi gold and polymetallic licenses in Iceland
  • Icelandic mineral licensing authority, Orkustofnun, has today approved the work programs submitted by the Company

Reykjavik – May 5, 2020 St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) is pleased to announce that it has received the permits, and thus, the green light for its 2020 seasonal work programs for the Vopnafjordur and Trollaskagi gold and polymetallic licenses in Iceland.

The Company announced on April 24, 2020, that it expected to be able to do work in June and July within the licenses. The Company submitted the work programs for approval on March 31, 2020.

The Icelandic mineral licensing authority, Orkustofnun, has today approved the work programs submitted by the Company.

Covid-19 Impact Assessments

The Icelandic government has further eased its Covid-19 restrictions. The pandemic is expected to have a limited impact on the work programs scheduled to commence shortly.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur Thor Vilhjalmsson”

Vilhjalmur Thor Vilhjalmsson
President and CEO

About St-Georges

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

#Google acts tough on ‘bad ads’; blocked nearly 1 million advertisers in 2019 – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 2:30 PM on Tuesday, May 5th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Google acts tough on ‘bad ads’; blocked nearly 1 million advertisers in 2019

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior to protect users from ads looking to take advantage of the crisis.

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior.

By: FE Online

  • Google on Monday said it disabled and eliminated 2.7 billion ‘bad ads’-more than 5,000 poor ads every minute-in 2019, and banned nearly a million advertisers responsible for policy breaches as part of its efforts to protect consumers from deceptive advertising.

The tech giant also noticed that fake advertisements for in-demand items such as face masks had a dramatic increase in the COVID-19 pandemic that claimed lakhs of life globally.

“Preserving the integrity of the ads on our platforms, as we’re doing during the COVID-19 outbreak, is a continuation of the work we do every day to minimise content that violates our policies and stop malicious actors. We have thousands of people working across our teams to make sure we’re protecting our users and enabling a safe ecosystem for advertisers and publishers…” Google has informed me in a blogpost.

The post, written by Google Vice President of Product Management Advertising Protection and Safety Scott Spencer, noted that in 2019, 2.7 billion bad advertising were blocked and taken out.

“We also suspended nearly 1 million advertiser accounts for policy violations. On the publisher side, we terminated over 1.2 million accounts and removed ads from over 21 million web pages that are part of our publisher network for violating our policies,” the blog said.

It added that terminating accounts-not just removing an individual ad or page-is a particularly effective enforcement tool that Google uses if advertisers or publishers commit egregious policy breaches or have a history of policy breaches.

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior to protect users from ads looking to take advantage of the crisis. Google said it has been closely tracking advertiser activity since the start of the COVID-19 outbreak to protect consumers from advertisers that are trying to take advantage of the crisis.

Google noted that there is a dedicated COVID-19 task force operating round the clock that has developed new detection technologies and has also improved existing compliance tools to avoid bad actors.

Source: https://www.financialexpress.com/industry/technology/google-acts-tough-on-bad-ads-blocked-nearly-1-million-advertisers-in-2019/1948767/

B2B edtech platform #Classplus bags $9m in series A funding – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 1:23 PM on Tuesday, May 5th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

B2B edtech platform Classplus bags $9m in series A funding

  • India’s Classplus, an edtech firm that enables offline coaching institutes to take their businesses online, said it has raised US$9 million in a series A round led by early-stage VC firm RTP Global.

By: Miguel Cordon

India’s Classplus, an edtech firm that enables offline coaching institutes to take their businesses online, said it has raised US$9 million in a series A round led by early-stage VC firm RTP Global.

Existing investors Blume Ventures, Spiral Ventures, Strive, and Sequoia Capital India’s accelerator, Surge, also participated in the round, according to a statement.

Classplus co-founders Bhaswat Agarwal (left) and Mukul Rustagi / Photo credit: Classplus

Hundreds of thousands of offline tutoring units in India, commonly called coaching centers, act as the primary source of academic support for more than 70 million students taking private lessons in the country every year.

Classplus aims to digitize this market by helping tutors run all their communications, payments, assessments, and learning programs online on their smartphones. AD. Remove this ad space by subscribing. Support independent journalism.

Its mobile-centric solution also acts as a digital distribution platform for educational content and products, enabling tutors to set up ecommerce channels to make video content and online assessments available to students.

The startup said it plans to use the new funds to improve its technology and expand its product offerings. It also looks to bolster its product, engineering, and business teams as well as make strategic hires for some leadership roles to drive its expansion.

According to Mukul Rustagi, the co-founder and CEO of Classplus, India is home to the largest after-school tuition market globally. “As national examinations move online, so must after-school tuition practices […],” he added.

Rustagi, along with co-founder Bhaswat Agarwal, launched Classplus in 2018. Since then, the startup has served over 1 million students across more than 70 Indian cities, with upward of 3,500 coaching centers using its technology.

Source: https://www.techinasia.com/classplus-bags-9m

Mota Ventures $MOTA.ca Acquires A Record 17,996 New Customers in April $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 11:05 AM on Tuesday, May 5th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

VANCOUVER, BC / ACCESSWIRE / May 5, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTC PINK:PEMTF) (the “Company“) is excited to announce for the month of April, it acquired 17,996 new customers. This represents an increase of 48% compared to April 2019. In April, the Company also experienced strong demand from customers enrolling in a subscription, totaling of 14,091 new subscribers during the month. This represents a new subscriber increase of 78% compared to April 2019.

The Company’s Natures Exclusive brand offers a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. Natures Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CDB skin serum and CBD coffee.

“We continue to see strong consumer demand for our entire range due to our concentrated customer acquisition efforts and by providing compelling products our customers are asking for. Our April new customer acquisition and subscription numbers are continued evidence of the strength of the business. Additionally, I am excited about our recent launch of a CBD hand sanitizer product and anticipate we will see very strong sales through this current quarter,” stated Ryan Hoggan, CEO of the Company.

The Company also announces that it has granted 7,995,000 incentive stock options to certain directors, officers and consultants of the Company. The options vest immediately, and are exercisable at a price of $0.30 for a period of 60 months. The options are governed by the terms of the Company’s incentive stock option plan, and the policies of the Canadian Securities Exchange.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brand. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Spyder $SPRD.ca Announces Licence to Open #Cannabis Retail Store in Calgary, Alberta $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:42 AM on Tuesday, May 5th, 2020
  • Received a licence from the Alberta Gaming, Liquor and Cannabis commission to open its first store in Calgary, Alberta
  • It is anticipated that the store, located at 104-58th Ave, SE, suite 140 Calgary, Alberta and operate as SPDR Cannabis,
  • Will open in the month of June.

Vaughan, Ontario–(May 5, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to announce that it has received a licence from the Alberta Gaming, Liquor and Cannabis commission (the “AGLC”) to open its first store in Calgary, Alberta. It is anticipated that the store, located at 104-58th Ave, SE, suite 140 Calgary, Alberta and operate as SPDR Cannabis, will open in the month of June. It will offer a full assortment of cannabis products from licenced producers.

“We are excited to open our first licenced cannabis store in Calgary, Alberta, a province which led the way in the rollout of the Canadian cannabis market. The store is ideally located in a busy hub of commercial retail establishments”, said Daniel Pelchovitz Spyder’s President & CEO. “We very much look forward to bringing the Spyder brand and retail experience focus to Calgary”.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward- looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]